"Ever since their foundation, BEKER® Laboratories have developed innovative product lines covering a wide range of therapeutic areas."
If health is priceless, it has too often a high cost for the patients and the community. This is why BEKER® laboratories were created in 2004, with a delicated team focused on a clear objective: To make accessible to all, the last generation treatments that meet International quality standards. At the core of our approach, there are three values: excellence, commitment, equity! BEKER® excellence is ﬁrst and foremost the production of effective treatments, starting from the work carried out within our Research and Development Center up to continuous quality control of our products. BEKER® excellence is also the partnerships that we tie day after day with all stakeholders in the drug supply chain, wherever we work, we do it by listening, sharing knowledge and anticipating needs. Finally, BEKER® excellence is what we offer to patients, to provide them every day with the best suitable treatment. A strong commitment of our employees, who carry BEKER® know-how with require- ment and good will. Performing and passionate teams, who work on a daily basis to develop more and more innovative product lines. Multidisciplinary teams that beneﬁt from continuous training focused on excellence. A commitment that is also translated through massive investments in R & D and high technology at all production stages. Excellence and collective commitment for the beneﬁt of patients, an equity requirement that underpins our mission and our willingness to bring the best treatments everywhere, to all. These are the values that make BEKER® a reference of the generic drug.
BEKER® Laboratories through action(s)...
Cure, Specialized in the manufacture of generic drugs, BEKER® laboratories offer treatments with composition in active ingredients that is quantitatively and qualitatively strictly similar to the originator drug and whose equivalence is systematically demonstrated for the granting of marketing authorization. Safe and
performing medications with a fair price, therefore making them accessible to all. Innovate. Thanks
to a team working daily in Research and Development, BEKER® Laboratories have made innovation a true industry policy. Every year, nearly 30 new drugs from the latest generation molecules are proposed for registration, and more than 20 are marketed For this purpose, not less than 10% of the turnover of the company is annually invested in R & D! A constant innovation that brings the laboratory to continually opening up new horizons for development, including sterile
anticancer products. Share. Treating efﬁciently
the greatest number : this is the ﬁrst ambition of BEKER® Laboratories who have made access to medicines the mainstay of their pricing policy. A commitment for better healthcare to all reﬂected through partnerships tied with all healthcare stakeholders in Algeria as in the rest of the world. Above all, it is a substantive approach that is part of BEKER® Laboratories DNA,complying with its core values: excellence, commitment, and equity. Raise awareness. Committed
to better healthcare, BEKER® laboratories do more than cure: they create and take part in information and prevention actions with professionals and the general public. BEKER® sponsors and contributes to scientiﬁc events for education and prevention purpo- ses, with direct link to the associations involved on the related diseases. Among the ongoing actions, BEKER® Laboratories are engaged in an extensive awareness and screening campaign for Hepatitis C with the
Algerian government. Guarantee. A pioneer
in pharmaceutical research and development in Algeria, BEKER® has built a solid reputation for excellence that has founded a genuine relationship of trust between the laboratory and the healthcare professionals. No fewer than 10,000 pharmacies through the territory offer its medicines every day to their
patients, medicines that have proven to be effective through bioequivalence studies. Transmit. BEKER®
Laboratories offer several opportunities of partnership to manufacturers throughout the world, enabling them to produce their own generic drugs adapted to their management pattern and the speciﬁcities of their markets. The objective: offer access to ever more patients across the globe to reliable, effective and affordable medicines, produced close to their homes on their territory. When the most economically efﬁcient solutions to the manufacturers provide healthcare to the large population…